Bone mineral density in patients with longstanding type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
Omar N. Alhuzaim(Mount Sinai Hospital), Bruce A. Perkins(Sinai Health System), Michael H. Brent(University of Toronto), Hillary A. Keenan(Joslin Diabetes Center), Marina Cardinez(Mount Sinai Hospital), David Z.I. Cherney(University Health Network), Leif E. Lovblom(University of Toronto), Alanna Weisman(Mount Sinai Hospital), Narinder Paul(University Health Network), Yuliya Lytvyn(University Health Network), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Evan J.H. Lewis(Mount Sinai Hospital), Geneviève Boulet(University of Toronto), Daniel Scarr(Mount Sinai Hospital)
Cited by 25
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470